Krystal Biotech (KRYS) Shares Outstanding (Diluted Average) (2020 - 2026)

Krystal Biotech has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $30.5 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $30.5 million, up 2.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.5 million (up 2.13% YoY), and the FY2025 annual result was $30.0 million, up 0.71% from the prior year.
• Shares Outstanding (Diluted Average) came in at $30.5 million for Q1 2026 at Krystal Biotech, up from $30.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $30.5 million in Q1 2026 to a low of $25.1 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $29.3 million (2024), against an average of $28.1 million.
• Across the five-year window, Shares Outstanding (Diluted Average) rose 18.17% in 2022 and increased 0.55% in 2025, its largest moves.
• Krystal Biotech's Shares Outstanding (Diluted Average) stood at $25.5 million in 2022, then advanced by 8.87% to $27.8 million in 2023, then gained by 7.16% to $29.7 million in 2024, then climbed by 0.71% to $30.0 million in 2025, then gained by 1.86% to $30.5 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $30.5 million (Q1 2026), $30.0 million (Q4 2025), and $29.8 million (Q3 2025), per Business Quant data.